These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 848928)

  • 1. Bone marrow toxicity associated with 5-fluorocytosine therapy.
    Kauffman CA; Frame PT
    Antimicrob Agents Chemother; 1977 Feb; 11(2):244-7. PubMed ID: 848928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of deep-seated fungal infections with 5-fluorocytosine.
    Firkin FC
    Aust N Z J Med; 1974 Oct; 4(5):462-7. PubMed ID: 4616675
    [No Abstract]   [Full Text] [Related]  

  • 3. Cryptococcal meningitis. Fatal marrow aplasia from combined therapy.
    Bryan CS; McFarland JA
    JAMA; 1978 Mar; 239(11):1068-9. PubMed ID: 628055
    [No Abstract]   [Full Text] [Related]  

  • 4. [Marrow aplasia and 5-fluorocytosine].
    Pris J; Chabrol H; Benchekroun S; Laurent G; Marty C; Denat S; Pelet
    Nouv Presse Med; 1980 Jan; 9(5):319. PubMed ID: 7355123
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity.
    Diasio RB; Lakings DE; Bennett JE
    Antimicrob Agents Chemother; 1978 Dec; 14(6):903-8. PubMed ID: 742878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of mycoses in children with 5-fluorocytosine].
    Aurich G; Feuerstein M; Plennert W; Zintl F
    Padiatr Grenzgeb; 1976; 15(5):241-7. PubMed ID: 1024180
    [No Abstract]   [Full Text] [Related]  

  • 7. Candida endocarditis treated with 5-fluorocytosine.
    Record CO; Skinner JM; Sleight P; Speller DC
    Br Med J; 1971 Jan; 1(5743):262-4. PubMed ID: 5212581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [5-fluorocytosine--a new antimycotic drug].
    Schönebeck J
    Lakartidningen; 1976 Jun; 73(25):2342-4. PubMed ID: 933638
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined treatment with amphotericin B and flucytosine in severe fungal infections.
    Eilard T; Beskow D; Norrby R; Wåhlén P; Alestig K
    J Antimicrob Chemother; 1976 Sep; 2(3):239-46. PubMed ID: 789322
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental endocarditis: prophylaxis of Candida albicans infections by 5-fluorocytosine in rabbits.
    Demierre G; Freedman LR
    Antimicrob Agents Chemother; 1979 Sep; 16(3):252-4. PubMed ID: 389156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monitoring of treatment involving 5-fluorocytosine].
    Dellamonica P; Fournier JP; Garraffo R; Lapalus P; Bernard E; Chichmanian RM; Marty P; Le Fichoux Y
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):642-5. PubMed ID: 3911161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Candida peritonitis by prolonged peritoneal lavage containing 5-fluorocytosine.
    Holdsworth SR; Atkins RC; Scott DF; Jackson R
    Clin Nephrol; 1975 Oct; 4(4):157-9. PubMed ID: 1192617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions.
    Vermes A; Guchelaar HJ; Dankert J
    J Antimicrob Chemother; 2000 Aug; 46(2):171-9. PubMed ID: 10933638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of sepsis by Candida in renal patients with 5-fluorocytosine].
    Rodicio JL; Ortuño MT; Alés JM; Hernando L
    Rev Clin Esp; 1974 Sep; 134(6):575-8. PubMed ID: 4615347
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-fluorocytosine-related bone-marrow depression and conversion to fluorouracil: a pilot study.
    Vermes A; Guchelaar HJ; van Kuilenburg AB; Dankert J
    Fundam Clin Pharmacol; 2002 Feb; 16(1):39-47. PubMed ID: 11903511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-fluorocytosine: a brief review.
    Ashe WD; Van Reken DE
    Clin Pediatr (Phila); 1977 Apr; 16(4):364-6. PubMed ID: 321173
    [No Abstract]   [Full Text] [Related]  

  • 17. Flucytosine: correlation between toxicity and pharmacokinetic parameters.
    Vermes A; van Der Sijs H; Guchelaar HJ
    Chemotherapy; 2000; 46(2):86-94. PubMed ID: 10671757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flucytosine.
    Bennet JE
    Ann Intern Med; 1977 Mar; 86(3):319-21. PubMed ID: 320931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future chemotherapy of central nervous system fungal infections.
    Utz JP
    Adv Neurol; 1974; 6():127-32. PubMed ID: 4480013
    [No Abstract]   [Full Text] [Related]  

  • 20. Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy.
    Francis P; Walsh TJ
    Clin Infect Dis; 1992 Dec; 15(6):1003-18. PubMed ID: 1457631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.